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Status of glomerular proteoglycans in aminonucleoside nephrosis.
Status of glomerular proteoglycans (PGs) in puromycin aminonucleo-
side nephrosis was investigated. Rats were made nephrotic and sacri-
ficed 0, 7, 14, and 21 days later. Maximal proteinuric response was
observed between 7 and 14 days. Prior to sacrifice, they received
injections of conjugated or unconjugated anti-heparan—sulfate—
proteoglycan antibody, directed against its core protein (Mr = 18,000).
Their kidneys were processed for direct and indirect immunofiuoresc-
ence, immunoperoxidase, tannic—acid staining, and tissue autoradi-
ography (ARO). By tannic—acid staining, antibody binding sites identi-
cal to the anionic sites described previously were discovered. No
qualitative differences were observed by these immunohistochemical
techniques. Quantitative tissue ARG did not reveal any statistical
differences in the binding of antibody between the control and nephrotic
groups. For de novo biosynthetic studies, rats were sacrificed on day
10. Their kidneys were utilized for labeling of basement membrane PGs
by employing [35S]-sulfate as the precursor product. Tissue ARG, as
well as biochemical studies, were performed on the radiolabeled
glomeruli. PGs were extracted with 4 M GuCI and characterized by
Sepharose CL-6B and DEAE-Sephacel chromatography. There was an
overall increase in the total incorporated radioactivities in the glomer-
ular and media fractions. No differences were observed in the macro-
molecular size characteristics of intact PGs and glycosaminoglycan
chains of either glomerular or media fractions. However, an increase in
the charge—density characteristics was observed in PGs of the nephrotic
group. By tissue ARG, an increase in the grain densities over the
basement membrane and mesangial matrices of the glomerulus was
noted. These data indicate that the intact PGs, their chains and core
protein do not undergo significant biochemical alterations; however, de
novo synthesized PGs have higher charge—density characteristics which
may be related to a higher degree of sulfation that occurs during the
course of aminonucleoside nephrosis.
Puromycin aminonucleoside (PAN) nephrosis in rats has
been a traditional model of minimal change disease [1, 2], the
most common cause of nephrotic syndrome in children. For
more than two decades, this model has been exhaustively
studied to investigate the pathogenetic mechanisms leading to
the leakage of proteins into the urine [3—30], and it has provided
many useful insights into the pathogenesis of proteinuria, one of
the hallmarks of dysfunction of glomerular capillaries [31].
Normally, the glomerular capillaries are endowed with both
size and charge—selective properties, which act in concert to
modulate the filtration of macromolecules [32]. According to
Received for publication September 29, 1986
and in revised form January 5, 1987
© 1987 by the International Society of Nephrology
the size—selectivity, the larger molecules have a more restricted
passage across these capillaries as compared to the small ones.
With respect to the charge—selective properties, the transcapil-
lary passages of various macromolecules seem to be as follows:
cationic > neutral>> anionic [33—35]. These charge—selective
properties are imparted by the cell surface—associated sialogly-
coproteins [36] and by the intrinsic glomerular basement mem-
brane (GBM) anionic sites, originally described by Rennke,
Cotran and Venkatachalam [33]. These anionic sites can be
demonstrated by various probes, such as lysozyme [37], ruthe-
nium red [38], cationic ferritin [33, 38], radioiodinated cationic
ferritin [39], polyethyleneimine [40], hexadimethrine [411, al-
cian blue [19], and cationic immune—complexes [42—44]. These
anionic sites were later found to be enriched with heparan
sulfate proteoglycan (HS-PG) residues [45, 46]. The proteogly-
cans (PGs) are made up of glycosaminoglycan (GAG) chains
(Mr = 25,000) which are covalently bound by 0-glycosidic
linkages to a core peptide (Mr = 18,000) via galactosyl-galac-
tosyl-xylosylserine [47—49].
Since the discovery of these anionic sites or PGs, a large
number of workers have investigated many facets of their status
with several different techniques [17, 19, 20, 22, 25—28]. These
investigations were carried out with the assumption that the
leakage of proteins, in particular that of anionic plasma albu-
min, may be related to the loss/reduction of the GBM anionic
sites or of the HS-PG. The results of these studies had been
somewhat inconclusive. In the present study, a comprehensive
examination of several aspects of PGs was carried out by
utilizing biosynthetic, biochemical, tissue autoradiographic,
and immunohistochemical techniques.
Methods
Animals
Charles River, female F-344 rates (Charles River Laborato-
ries, Wilmington, Massachusetts, USA) weighing 100 to 120
grams were obtained and maintained in in—house animal facili-
ties with food and water ad libitum.
Induction of nephrosis
Sixty—four animals were used to investigate the status of core
protein of GBM:HS-PG by immunohistochemical and tissue
autoradiographic techniques. Nephrosis was induced by admin-
istration of a single intravenous injection of PAN (15 mg/l00 g
body wt) [10, 27, 28]. Sixteen control animals were sacrificed on
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Table 1. Number of animals used in various techniques
Technique
Day of sacrifice
0 7 10 14 21
Indirect immunofluorescence 4 4 4 4
Direct immunofluorescence 4 4 4 4
Tannic acid 4 4 4 4
Immunoperoxidase 4 4 4 4
Autoradiography ('251-antibody) 4 4 4 4
Biochemical studies 6(6)
Autoradiography (["SI-sulfate) 6(6)
a Indicates 6 control and 6 experimental animals in each group.
day 0. The remaining animals, three groups of 16, were sacri-
ficed 7, 14, and 21 days following the administration of PAN.
Prior to sacrifice, 24-hour urinary protein excretions were
determined [50].
Another 12 animals were utilized for determining the status of
de novo synthesized HS-PG by biochemical and tissue autora-
diographic techniques. Six animals were made nephrotic and
sacrificed ten days later, while the remaining six served as
controls. A summary of the number of animals utilized in each
group for immunofluorescent (direct and indirect), immunoper-
oxidase, biochemical, and tissue autoradiographic studies is
given in Table 1.
Preparation and conjugation of antibody
Polyclonal antibodies were raised in rabbits against the core
protein of GBM:HS-PG [48], and IgG fraction was obtained.
The preparation of antigen, antibody and authenticity of spec-
ificity has been detailed in our previous publications [48, 51].
The IgG fraction of the antibody was utilized for conjugation
with either horseradish peroxidase (HRPO) or '251-iodine. Con-
jugation of IgG-antibody with HRPO was performed by follow-
ing the method of Nakane and Kawaoi [52]. Radioiodination of
IgG-antibody was carried out by the method of glucose
oxidase:lactoperoxidase as previously described [39, 53]. Free
peroxidase and '251-iodine were removed by extensive dialysis
against phosphate—buffer saline (PBS), pH 7.4, followed by
Sephadex (G-25) chromatography. The final concentration of
the radioiodinated or conjugated antibody was adjusted to 100
mg/mI in PBS.
In vitro labeling of HS-PG (anionic sites) and indirect
immunofluorescence
Animals in groups of four were sacrificed 0, 7, 14, and 21 days
after induction of nephrosis. Alter their kidneys were obtained,
transected, and snap—frozen in chilled isopentane, 4-pm-thick
cryostat sections were prepared. The sections were incubated
with rabbit anti-HS-PG antibody at 37°C for 30 minutes. Fol-
lowing two washings with PBS (15 minutes each), the sections
were reincubated with fluoresceinated anti-rabbit IgG (Cooper
Biomedicals Co., Malvern, Pennsylvania, USA) for another 30
minutes. The sections were then washed twice, covered with a
drop of buffered glycerol, cover—slip mounted, and examined
by an immunofluorescent microscope equipped with a photo-
graphic assembly.
In vivo labeling of HS-PG (anionic sites), and
direct—immunofluorescent and tannic—acid staining
A similar set of animals, as indicated above, were utilized and
sacrificed at varying intervals. Six hours prior to sacrifice, each
animal received an intravenous injection of anti-HS-PG anti-
body (25 mg/tOO g body wt). Following anesthesia, their left
kidneys were flushed with normal saline, fixed by perfusion
with 1% glutaraldehyde plus 0.2% tannic acid in 0.1 M cacodyl-
ate buffer, pH 7.4, and processed for electron microscopy. The
right kidney was transected and snap-frozen, then 4-sm-thick
cryostat sections were prepared. The sections were incu-
bated with fluoresceinated anti-rabbit IgG, washed, cover—slip
mounted, and examined under the immunofluorescent micro-
scope.
In vivo labeling of HS-PG (anionic sites) with peroxidase
conjugated antibody
Animals, in groups of four, were sacrificed at various stages
of nephrosis. Six hours prior to sacrifice, each animal received
an injection of IgG fraction of anti-HS-PG antibody (25 mg/100
g body wt) conjugated with peroxidase. Their kidneys were
obtained, transected, immersed in 10% DMSO contained in
PBS, and snap—frozen. Alter 16-pm-thick cryostat sections
were made, they were floated in small beakers containing 1%
oval albumin in PBS (0.5 M NaCI), and a classic diaminoben-
zedine reaction was carried out [54]. The sections were then
immersed in an aldehyde fixative, dehydrated, and flat—
embedded in EPON. Approximately 0.5-pm-thick sections
were made with glass knives, lightly stained with 1% toludine
blue, and examined with a light microscope.
In vivo labeling of anionic sites with radioiodinated
anti-HS-PG antibody
To quantitate the binding of the antibody to the core peptide
of HS-PG, another set of animals, in groups of four, received
injections of radioiodinated antibody (25 mg/100 g body wt, 2.5
x l0 CPM). They were sacrificed six hours later, and their
kidneys were fixed by perfusion with an aldehyde fixative. One
mm3 blocks were made, osmicated, dehydrated, and embedded
in EPON. Thick (0.5 pm) and thin (60 nm) sections were
prepared and processed for light (LM) and electron microscopic
(EM) autoradiography, respectively [27, 39, 53].
Ex vivo labeling of GBM proteoglycans
Radiolabeling of proteoglycans was carried out with [355]
sulfate as the precursor product in an isolated organ—perfusion
system [55]. The kidneys from nephrotic or control animals
were flushed with Krebs—Ringer bicarbonate (KRB) solution
and then their arterial stumps connected to a recirculating
perfusion system. The perfusion medium included KRB solu-
tion containing 10% bovine serum albumin (BSA), a mixture of
amino acids and [35S]-sulfate (500 xCiJml). The PGs were
labeled for seven hours, then a biopsy of the kidney was taken:
tissue was diced into 1 mm3 pieces, aldehyde—fixed, and proc-
essed for EM autoradiography. The kidney itself was perfused
with KRB-BSA solution containing a mixture of protease
inhibitors, bisected, and kept frozen at —20°C until further use.
The perfusion media were also saved for characterization of
PGs or GAGs.
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Characterization of proteoglycans and glycosaminoglycans
Glomeruli were isolated from the frozen kidneys by the
sieving method, and de novo synthesized PGs were extracted
with 4 M guanidine HC1 in the presence of protease inhibitors
[47—49]. The extracts were dialyzed against ice—cold distilled
water containing protease inhibitors, aliquoted, and kept frozen
at —20°C. An aliquot was used for determination of total
radioactivity present in one kidney. Initially, the intact (native)
extracted PGs were characterized by Sepharose CL-6B column
chromatography, before and after treatment with nitrous acid or
chondroitinase-ABC [47—49]. Similarly, the GAG chains ob-
tained after alkaline borohydride treatment were characterized.
The charge—density characteristics of intact proteoglycans were
determined by DEAE-Sephacel chromatography [49]. In the
latter, the proteoglycans were eluted with a continuous gradient
of 0.1 to 1.0 M NaCL on a DEAE-Sephacel column (total bed
volume = 5 ml), and radioactivities were determined in each of
the 40 effluent fractions of I ml each.
The media PGs were characterized as previously described
[49]. The PGs were isolated from the media by Sephadex G-50
chromatography. The excluded fractions were collected, dia-
lyzed against distilled water, and lyophilized. They were then
characterized by DEAE-Sephacel and Sepharose CL-6B chro-
matography as described above. Aliquots of the purified frac-
tions of media PGs were also utilized for determination of total
radioactivities.
Tissue autoradiography and morphometric analysis
Autoradiography was carried out on tissues in which native
HS-PGs were labeled with radioiodinated antibody directed
against the core peptide and also on the tissues in which de novo
synthesized HS-PG were labeled with [35S}-sulfate. The proce-
dures for tissue autoradiography have been extensively detailed
in our previous publications [27, 39, 53]. The glomeruli labeled
with radioiodinated antibody were subjected to LM autoradi-
ography and morphometric analysis. Twenty glomeruli from
four animals were included in each group. They were photo-
graphed and then printed at a final magnification of x 1,500. The
area of capillaries, localization of grains, and the grain density
(number of grains/area) were determined by methods of Weibel
[56] and Salpeter and Bachman [57] as detailed previously [27,
39, 53]. EM autoradiography was carried out to confirm the
localization of silver grains on the GBM. The tissues from
experiments dealing with de novo synthesized HS-PG were
subjected to EM autoradiography and morphometric analysis.
Twenty—five glomerular capillary loops from each group of
animals were photographed and printed at a final magnification
of x 15,000. The area of the GBM, number of grains on the
GBM, and the grain densities (concentration of radiation) were
then determined as described above.
Results
A consistent proteinuric response was obtained in animals
made nephrotic, and their respective 24-hour urinary protein
excretions per 100 g body weight were as follows on 0, 7, 14,
and 21 days after the administration of PAN: 1.1 0.4, 238.8
70.8, 253 88.6, and 50.8 1.6. The basic aim of these studies
was to investigate the alterations in the macromolecular struc-
ture of the HS-PG in nephrotic states from two different
aspects. The first, dealing with the changes in the core protein,
is ascertained by immunohistochemical methods; the second,
pertaining to the de novo synthesized GAG chains of HS-PG, is
determined by labeling with the precursor product, that is,
[35S]-sulfate. Thus, a multitude of techniques was employed to
delineate the changes in the GBM:HS-PG in PAN nephrosis.
Immunohistochemical studies
By indirect immunofluorescence, a linear pattern of staining
of GBM and tubular basement membranes (TBM) was observed
(Fig. 1, A—D). The Bowman's capsule of the glomerulus and the
vascular basement membranes were also stained. No mesangial
or cytoplasmic staining was observed. The intensity of staining
in glomeruli from different stages of nephrosis did not change
appreciably. In fact, after examining many sections, it seemed
that the GBM staining on the seventh and fourteenth days of
nephrosis was somewhat accentuated. Similarly, no significant
change in the intensity of staining in the TBMs was detected.
By direct immunofluorescence, a very delicate, fine—linear
pattern of staining of GBMs was observed (Fig. 1, E—H). No
staining of TBMs was observed since by in vivo labeling the
TBM anionic sites are not accessible to the circulating anti-
body. The intensity of staining again appeared to be somewhat
more in tissue obtained from animals sacrificed on the seventh
and fourteenth days of nephrosis.
By immunoperoxidase technique, a linear brownish reaction
product was seen over the basement membranes of the
glomerulus. No distinct change in the intensity of the reaction
product was observed in any stage of nephrosis (Fig. 1, I—L).
Also, no reaction product was seen over the cell surfaces,
mesangium, or TBM. Some of the intra-renal vascular base-
ment membranes were seen to be stained as well.
Tannic acid experiments
These experiments were performed to achieve two main
objectives: first, to ascertain whether the intravenously admin-
istered antibody indeed binds to the anionic sites enriched in
HS-PG residues, and second, to ascertain any qualitative
change in the anionic sites during nephrosis. From our previous
experience [51], it seems that by tannic acid treatment we can
demonstrate the antigen—antibody complexes in the laminae
rarae of the GBM. As shown in Figure 2, a periodic pattern of
antibody localization is seen in the laminae rarae with distribu-
tion identical to that of anionic sites previously demonstrated
by various cationic probes [37—44]. This meant that anti-HS-PG
antibody is specific in that it binds to the anionic sites enriched
with HS-PG residues. As far as the changes in the distribution
of the binding of the antibody, no qualitative differences were
observed in any stage of nephrosis, either in lamina rara externa
or interna.
Radioimmunohistochemical studies
To ascertain the quantitative change in the core protein of
GBM:HS-PG during various stages of nephrosis, tissue autora-
diographic studies were performed after administration of ra-
dioiodinated antibody. No significant change in the number of
grains was observed in the LM of EM tissue autoradiography
(Figs. 1 M—P and 3). The morphometric analysis performed on
the LM autoradiograms did not reveal any statistically signifi-
cant differences (Table 2). The mean grain densities on the LM
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Fig. 1. Light micrographs of glomeruli from kidneys of animals on 0 (A, E, I, M) 7 (B, F, J, N), 14 (C, G, K, 0) and 21 (D, H, L, P) days after
administration of puromycin aminonucleoside (PAN). No significant differences are observed, in various stages of PAN nephrosis, by indirect
(A—D) and direct (E—H) immunofluorescence, or by frozen tissue immunoperoxidase (I—L) and light microscopic autoradiography (M—P)
techniques. x 400.
autoradiogram for 0, 7, 14, and 21 days of nephrosis were: 15.8
2.97, 13.03 2.45, 16.53 3.82, and 16.78 3.73, respec-
tively. Thus, the data indicated that there are no appreciable
alterations in the core protein of native HS-PG, as ascertained
by many immunohistochemical techniques. These studies then
lead to further investigation of the characterization of de novo
synthesized HS-PG, in particular the GAG chains and charge
densities contributed by the sulfate radicals of the PGs.
Characterization of de novo synthesized proteoglycans
The tissues for characterization of PGs were obtained at the
time when animals had maximal well—established proteinuric
response, that is, tenth day after administration of PAN. Total
incorporated radioactivities (efficiency of extraction >95%) in
glomerular fractions per kidney were 0.90 x 106 DPM and
- 1.5 x 106 DPM in control and nephrotic groups, respectively
(Table 3). Similarly, the total incorporated radioactivities in
media fractions of nephrotic animals were much higher than
that of the control. The radioactivities in the media of control
and nephrotic kidneys were -9.5 x 106 DPM and - 2.9 x l0
DPM, respectively. This indicated that there is some stimula-
tion in the de novo synthesis of PGs in the nephrotic states.
Sepharose CL-6B chromatograms of the intact PGs from
normal and nephrotic animals revealed identical elution pro-
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Fig. 2. Electron micrographs of portions of glomerular capillary loops from kidneys of animals with PAN nephrosis, on day 0 (A), 7(B), 14 (C)
and 21(D). By tannic acid treatment, the anti-HS-PG antibody is visualized bound at periodic intervals (black and white arrows) in the laminae
rarae of glomerular basement membrane, and its distribution seems to be identical to that of anionic sites. No alterations in the distribution of the
antibody binding is seen during various stages of PAN nephrosis. Abbreviations are: US, urinary space; Ep, epithelium; fp, foot processes; En,
endothelium; Cap, capillary lumen. x 40,000.
files, except the peaks of higher radioactivities were seen in the About 95% of the radioactivity was released into the Vt fraction
latter (Fig. 4A vs. 4B). In control, a single major peak with Kay after nitrous acid treatment, while successive treatments with
value of 0.26 (mol wt = 130 to 150,000) was observed (Fig. 4A). chondroitinase-ABC and nitrous acid released 100% of the
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FIg. 3. Electron microscopic autoradiographs of glomerular capillaries from kidneys of animals with PAN nephrosis, on day 0 (A), 7(B), 14 (C)
and 21(D). After administration of radioiodinated antibody, it is seen localized to the glomerular basement membrane, as indicated by the black
and white arrows. No significant differences are seen in binding of the antibody during various stages of nephrosis. Abbreviations are: US, urinary
space; Ep, epithelium; fp, foot processes; En, endothelium; Cap, capillary lumen. X 16,000.
radioactivity into the Vt fraction (Fig. 4A). Similar profiles were
observed when extracts of nephrotic animal tissues were
treated with chondroitinase-ABC and nitrous acid (Fig. 4B).
This suggested that no significant change in the macromolecular
size of the intact PGs occurred during nephrosis.
The elution profiles of GAG chains obtained after alkaline
hydrolysis also had identical profiles in control and nephrotic
groups (Fig. 4 C and D). A single peak with Kay value of 0.48
(mol wt = 20 to 25,000) was observed. No change in the GAG
chain size was observed in nephrotic group. The chemical
characteristics of GAG chains were also similar. The GAG
chains, like the intact PGs, were mostly made up of heparan
sulfate.
Subtle differences were found in the PGs extracted from
tissues of control and nephrotic animals in terms of charge—
density characteristics. The DEAE-Sephacel chromatography
revealed that intact PGs from tissues of control animals eluted
between 0.35 and 0.45 M NaCI fractions of the gradient (Fig.
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Table 2. Radioiodinated antibody binding data, mean SD
Day of
sacrifice Total grains Total area
Grain
densities
0 316.90 81.50 20.60 5.99 15.80 2.97
7 294.15 75.46 23.00 6.85 13.03 2.45
14 348.95 97.17 18.95 4.97 16.53 3.82
21 276.41 77.72 16.68 4.58 16.78 3.73
4E), while the PGs of nephrotic animals eluted at a higher
molarity fractions of the gradient, that is, between 0.45and 0.55
(Fig. 4F). This suggested that in nephrotic states some sort of
change in the charge—density of PGs characteristics may have
occurred.
The media PGs did not reveal any macromolecular change in
terms of their size. However, the total incorporated radioactiv-
ity was three times that of the control in tissues from nephrotic
animals (Table 3). By Sepharose CL-6B chromatography, two
peaks of radioactivity with Kay values of 0.26 and 0.48
were observed (Fig. 5A). The first peak represented the intact
PGs, while the second mostly included the GAG chains. The
majority of the radioactivity in both peaks was confined to
heparan sulfate species of PGs, since after nitrous acid treat-
ment - 90% counts were recovered in the Vt fraction after
successive treatments with chondroitinase-ABC and nitrous
acid. Almost similar elution profiles were seen with media
fractions of kidneys from nephrotic animals (Fig. SB). Interest-
ingly, the PGs/GAGs of media fractions from control and
experimental groups exhibited differences in their charge—den-
sity characteristics similar to that of intact glomerular PGs. In
control, by DEAE-Sephacel chromatography (Fig. SC), the
medium PGs eluted betwen 0.3 and 0.4 M NaCl fractions of the
gradient, while the PGs of nephrotics eluted between 0.35 and
0.45 M NaC1 fractions of the gradient (Fig. SD). This meant that
the charge-density characteristics of both the intact PGs and
the GAG chains are possibly altered in nephrotic states.
Tissue autoradiography of de novo synthesized HS-PG
General morphology of glomerulus remained preserved dur-
ing the seven hours of perfusion. Autoradiographic grains were
seen on all the cell types of the glomerulus and extracellular
matrices, that is, GBM and mesangial matrix (MM). Most of the
grains over the cells could be localized to the Golgi apparatus.
Qualitatively, subtle differences were observed in the number
of grains localized over the GBM in control versus nephrotic
groups (Fig. 6A vs. 6B). Because of the complexity of the
podocytes in nephrotic state, the grain densities were deter-
mined on the GBMs only. The grain densities over the GBMs
revealed significant differences. The mean grain densities of
control and nephrotic groups were 0.48 0.02 and 0.63 0.02
(Table 4), respectively. In both the control and nephrotic
groups, many grains were seen in transit from the epithelium to
the final matrix sites (Fig. 7C). The grains were also seen in the
denuded regions of the GBM with the same frequency as
observed in the regions where cellular integrity of the capillaries
was preserved in the nephrotic group (Fig. 7D). As compared to
the control, a qualitative increase of the autoradiographic grains
in the mesangial matrices of nephrotic animals was observed as
well (Fig. 7A vs. 7B).
Table 3. Radioactivities in glomerular and media fractions
Control Nephrotic
Glomerular fraction —0.90 x l0 dpm --1.5 x 10 dpm
Media fraction —9.5 x 106 dpm —2.9 x l0 dpm
Table 4. Total grains (TG), total area (TA) and grain densities (GD)
of electronmicroscopic autoradiography data
Control Nephrotic
TG TA GD TG TA GD
Kidney 1 156 320 0.49 232 389 0.60
Kidney 2 141 288 0.49 160 244 0.66
Kidney 3 180 371 0.49 229 358 0.64
Kidney 4 168 376 0.45 183 300 0.61
Kidney 5 164 315 0.52 244 401 0.61
Kidney 6 145 310
(0
0.47
.48 O.02)a
254 398
(0.63
0.64
0.02)a
a Mean grain density SD
Discussion
With the use of a multitude of techniques, the data obtained
in this investigation indicate that there are no significant alter-
ations in the native PGs, in particular the core protein of HS-PG
during PAN nephrosis. In addition, it seems that the macromo-
lecular size of de novo synthesized HS-PG and its GAG chains
also remains unaltered to a large extent. However, a mild
increase in the charge-density of GBM:HS-PG, as ascertained
by DEAE-Sephacel chromatography, was observed. If the very
anionic sites described by Rennke, Cotran, and Venkatachalam
[33] are considered to be representative of sulfate residues of
HS-PG, then the results of this investigation suggest that there
are no significant changes in them to account for the loss of
charge—selectivity observed in various forms of experimental or
clinical nephrosis. In order to account for the loss of
charge—selectivity, further research is needed to search for the
anionic proteins present within the substance of the GBM or on
the cell surfaces.
The tannic—acid staining data indicate that the antibody
directed against the core peptide of HS-PG binds to the lamina
rara interna (LRI) and externa (LRE) with periodicity identical
to that of anionic sites, demonstrated previously by various
cationic probes [37—44]. The distribution of binding of the
antibody remained unchanged in both LRE and LRI. These
results further substantiate some of our earlier observations of
PAN nephrosis [22, 27], while they differ in some respects from
others [17, 19, 26]. No change was observed when probes like
cationic ferritin, '251-cationic femtin, cytochrome-C, and ruthe-
nium red are employed [22, 27]. A change in the form of
reduction in the anionic sites was reported when the probes like
lysozyme and alcian blue were used [17, 19]. Previously, these
discrepancies in the results were rationalized on the basis of the
characteristics and specificities of the probes used in a given
investigation. For example, the lysozyme with a higher p1
(>10.5) probe is expected to bind to the sulfate and carboxylate
groups of the anionic sites present in the GBM or on the cell
surfaces. On the other hand, the cationic ferritin with lower p1
20 40 60
Fraction
Fig. 4. Sepharose CL-6B (A-D) and
DEAE-Sephacel (E-F) chromatograms of
aliquots of glomerular extracts of normal (A,
C, E) and nephrotic (B, D, F) animals. A and
B represent elution profiles of intact
,80 proteoglycans before (—) and after
treatment with nitrous acid ( ) or
chondroitinase-ABC plus nitrous acid (- -). C
and D represent elution profiles of
glycosaminoglycan chains, obtained after
alkaline borohydride treatment. No change in
z the molecular size of the intact proteoglycan
or their chains is observed, except that the
elution peaks contain relatively higher amount
of radioactivities in the nephrotic group. By
DEAE-Sephacel chromatography, the
proteoglycans of the control group eluted
between 0.35 and 0.45 M (E), while that of
nephrotic between 0.45 and 0.55 M NaC1 (F)
fractions of the gradient.
(7.2 to 7.4) binds specifically to the sulfate residues of HS-PG polycarboxylate groups of a given particular protein!
since the binding was lost after heparitinase treatment [45, 46]. glycoprotein of the GBM may be altered, and that probably is
In view of the differences in their p1, differential binding reflected in the reduction in the binding of lysozyme or alcian
patterns are expected. Thus, it is conceivable that the blue. However, the anionic groups representative of HS-PG to
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Fig. 5. Sepharose CL-6B (A, B) and
DEAE-Sephacel (C, D) chromatograms of
aliquots of perfusion media fractions of
normal (A and C) and nephrotic (B and D)
animals. Sepharose CL-6B chromatograms
reveal similar elution profiles of proteoglycans
(peak A)/glycosaminoglycans (peak B) for the
control (A) and nephrotic (B) groups, before
0 8 (—) and after treatment with nitrous acidjL ( ) or chondroitinase-ABC plus nitrous acid(- . -). The peaks of radioactivities arerelatively higher in the nephrotic (B) as0.4 . compared to the control group (A). ByDEAE-Sephacel chromatography, theproteoglycan—glycosaminoglycan of thecontrol group eluted between 0.3 and 0.4 M
10 20 30 40 (C), while that of nephrotic between 0.35 and
Fraction 0.45 M NaCl (D) fractions of the gradient.Fraction
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Fig. 6. Electron microscopic autoradiographs of glomerular capillaries from kidneys, ex vjvo labelled with [35S1-sulfate, ofanimals with PAN
nephrosis, on day 0(A) and 10 (B). Several autoradiographic grains are seen localized to the glomerular basement membrane (GBM), as indicated
by the black and white arrows. There seems to be more grains over the GBM of capillaries from nephrotic animal (B) as compared to the control
(A). Abbreviations are: US, urinary space; Ep, epithelium; fp, foot processes; En, endothelium; Cap, capillary lumina. A, X 16,000, inset,
x 10,000; B, x 25,000, inset, X 10,000.
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Fig. 7. Electron microscopic autoradiographs of glomerular mesangium (A, B) and capillary loops (C, D) from kidneys, ex vivo labelled with
[35S]-sulfate, of animals with PAN nephrosis, on day 0 (A and C) and 10 (B and D). Several autoradiographic grains are seen localized to the
glomerular basement membrane (GBM) and mesangial matrix (MM), and are indicated by arrows. There seems to be more grains on the GBM and
MM of nephrotic animal (B and D) as compared to the control (A and C). The increased grain density, in the nephrotic group, is readily observed
also in the regions of GBM which are focally denuded of the cellular elements (D). Normally, it seems that the sulfated proteoglycans are
synthesized by the visceral epithelium (Ep, site #1), pass through the foot processes (fp, site #2) and reach the GBM matrix (site #3). The transit,
from original to final destination sites, is illustrated in C. Abbreviations are: US, urinary space; En, endothelium; Cap, capillary lumen. A, X 8,000;
B, x 6,500; C, x 7,500; D, x 10,000.
which cationic ferritin binds remain unchanged in PAN
nephrosis. This latter notion is further strengthened by the
present immunohistochemical data. Furthermore, it appears
from the tannic acid experiments that there is not appreciable
change in sites, either of LRE or LRI, to which antibodies bind
during the entire course of nephrosis. In this regard, by em-
ployment of polyethyleneimine specific alterations in the an-
ionic sites of LRE had been reported in PAN nephrosis [25].
Here again, the discordancy in the results can be explained on
the basis that binding of probes to the anionic sites may be
nonspecific or indiscriminate. Henceforth, as indicated earlier,
it may be that the residues other than sulfate radicals may be
altered in PAN nephrosis.
The present results are also at variance with immunohis-
tochemical data obtained previously [26]. The non-congruency
of the results can be discussed from many aspects. First of all,
the source of antigen and epitope towards which antibody is
directed may be different. On one hand, one is dealing with
antibody directed against HS-PG derived from EHS-sarcoma,
while in the present investigation it is directed against the
HS-PG isolated directly from native GBMs. Thus, because of
different antigen sources, differences in the antibody binding
and recognition of separate antigenic determinants are ex-
pected. Moreover, several macromolecular dissimilarities be-
tween the two HS-PGs are very well known [48]. Another
reason for the discordance may be related to the technique with
which the antibody binding was investigated. In our hands, the
immunoperoxidase technique (light or electron microscopic) for
aldehyde—fixed tissues did not yield consistent results at all.
Therefore, we only employed the frozen—tissue immunoper-
oxidase technique, whereby consistent results were obtained
and confirmed by immunofluorescent and radioimmunohisto-
chemical techniques. In a nutshell, with the employment of
these different techniques, convergent results were obtained
which indicate an unaltered state of the core protein of
GBM:HS-PG.
The studies to investigate the macromolecular characteristics
of de novo synthesized core protein HS-PG are not feasible at
the present time because of technical limitations. Therefore, the
status of either intact PGs or their GAG chains was investi-
gated. The results to a large extent corroborate with the data on
the core protein and, to a certain degree, with the studies
carried out on isolated glomeruli [28]. However, there are
certain differences between the data obtained in glomerular
cultures and isolated kidney perfusion systems. The differences
may be related to the change in the phenotypic expressions,
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such as, in the glomerular system substantially more synthesis
of chondroitin sulfate has been reported [58]. This, in turn, may
be related to the poor viability of visceral epithelium in the
glomerular culture, since it is severely damaged during the
sieving procedures. At present it appears that the visceral
epithelium is the major cell type which synthesizes the
GBM:HS-PG [48, 59—61], while the mesangial cell is primarily
involved in the synthesis of chondroitin sulfate [62]. It may be
that relatively higher synthesis of chondroitin sulfate in glomer-
ular system may be due to the selective viability of mesangial
cell, the cell which is minimally injured during sieving proce-
dures.
Regardless of the drastic differences in the techniques, there
appears to be some convergence in the data, such as: (a) there
is no overall drastic change in the macromolecular size charac-
teristics of the HS-PG, and (b) apparently, there is a generalized
increase in the synthesis of HS-PG. The additional data in-
cluded in this investigation indicate that there may be subtle
changes in the charge—density characteristics of the de novo
synthesized PGs. In PAN nephrosis, the de novo synthesized
PGs possibly have a higher charge—density, probably related to
a relatively accentuated sulfation of GAG chains of PGs. The
higher degree of sulfation may explain the increased amount of
total incorporated radioactivities recovered in the glomerular
and media fractions. The reason as to why the glomerular cells
would step up the sulfation process in PAN nephrosis is not
clear at the present time. As suggested previously [28], the
increased synthesis of HS-PG in PAN nephrosis may be a
compensatory response to the increased degradation or turn-
over of other GBM glycoproteins [8, 9]. Along with this, a
compensatory increased synthesis of core protein would occur
which ultimately may be reflected in an accentuated de novo
synthesis of HS-PG. However, this event seems to be unlikely
since the qualitative and quantitative studies do not indicate any
change in the core protein during nephrosis. It may be that there
is a tenuous change in the de novo synthesis of core protein of
HS-PG which cannot be delineated with the technology em-
ployed in the present investigation. Alternatively, the de novo
synthesized HS-PG may have different interactions with other
basement membrane components, that is, type IV collagen or
laminin, which may perturb the overall charge-density charac-
teristics of the GBM and that could account for the loss of
charge—selectivity in PAN nephrosis.
In summary, it appears that there are no significant changes
in the macromolecular composition of GBM:HS-PG, except for
possible post-translational modification in the charge-density
characteristics. As a consequence, there may be defective
interactions with other components and improper macromolec-
ular assemblage of the GBM. This, ultimately, may be able to
explain the pathogenesis of proteinuria in PAN nephrosis.
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